Apium Pharmaceutical Private Limited

Produces various medicines to prevent, diagnose, and cure diseases. WHO-GMP certified.

2009 | Raigarh, Maharashtra (India) | Active
Last Updated:

Apium Pharmaceutical Profile

Key Indicators

  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 1.50 M
  • Company Age 15 Year, 10 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth 5.46%
  • Profit Growth -12.47%
  • Ebitda -17.62%
  • Net Worth 51.95%
  • Total Assets 2.25%

About Apium Pharmaceutical

Apium Pharmaceutical Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 April 2009 and has a history of 15 years and ten months. Its registered office is in Raigarh, Maharashtra, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M, as per Ministry of Corporate Affairs (MCA) records.

Subhash Musale and Rekha Musale serve as directors at the Company.

Company Details

  • Location

    Raigarh, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    apium.in

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24239MH2009PTC192026

  • Company No.

    192026

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    24 Apr 2009

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Pharma

What products or services does Apium Pharmaceutical Private Limited offer?

Apium Pharmaceutical Private Limited offers a wide range of products and services, including Antibiotic Injection, Piperacillin Tazobactam Injection, Antibiotic Tablets & Capsules, Azithromycin Tablets, Ceftriaxone Injection, Cough Syrup, Anti Inflammatory Drugs, Nimesulide Tablet, Anti Infective Drugs & Medicines, Antibacterial Drugs.

Who are the key members and board of directors at Apium Pharmaceutical?

Board Members (2)

NameDesignationAppointment DateStatus
Subhash Musale Country flag representing In Director 24-Apr-2009Current
Rekha Musale Country flag representing In Director 01-Dec-2012Current

Financial Performance of Apium Pharmaceutical.

Apium Pharmaceutical Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.46% increase. The company also saw a substantial fall in profitability, with a 12.47% decrease in profit. The company's net worth Soared by an impressive increase of 51.95%.

Apium Pharmaceutical revenue growth over time
Apium Pharmaceutical profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
5.46%
Revenue from Operations
5.38%
Total Assets
2.25%
Profit or Loss
-12.47%
Net Worth
51.95%
EBITDA
-17.62%

What is the Ownership and Shareholding Structure of Apium Pharmaceutical?

Unlock access to Apium Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Apium Pharmaceutical?

Unlock and access historical data on people associated with Apium Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Apium Pharmaceutical Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Apium Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apium Pharmaceutical's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Apium Pharmaceutical

Recent activity within the organization

  • Annual General Meeting

    Apium Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Apium Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.

  • Director Appointment

    Rekha Subhash Musale was appointed as a Director was appointed as a Director on 01 Dec 2012 & has been associated with this company since 12 years 3 months .

  • Director Appointment

    Subhash Punjabrao Musale was appointed as a Director was appointed as a Director on 24 Apr 2009 & has been associated with this company since 15 years 10 months .

  • Company Incorporation

    Apium Pharmaceutical Private Limited was registered on 24 Apr 2009 with Roc Mumbai & aged 15 years 10 months as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Apium Pharmaceutical Private Limited?

    Apium Pharmaceutical Private Limited was incorporated on 24 Apr 2009.

  • What is authorized share capital and paid-up capital of Apium Pharmaceutical Private Limited?

    The authorized share capital of Apium Pharmaceutical Private Limited is ₹ 1.50 M and paid-up capital is ₹ 1.50 M.

  • Who are the current board members & directors of Apium Pharmaceutical Private Limited?

    Currently 2 directors are associated with Apium Pharmaceutical Private Limited.

    • Subhash Punjabrao Musale
    • Rekha Subhash Musale
  • What is the registered address of Apium Pharmaceutical Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Apium Pharmaceutical Private Limited is C/O Rekha S. Musale Fl-104 Pl-20 Sect-5, Ulwe Navi Mumbai India, Khalapur, Maharashtra, 410206.

  • What is the corporate identification number (CIN) and company number of Apium Pharmaceutical Private Limited?

    The corporate identification number (CIN) of Apium Pharmaceutical Private Limited is U24239MH2009PTC192026 and the company number is 192026 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Apium Pharmaceutical Private Limited?

    The Official website of Apium Pharmaceutical Private Limited is https://www.apium.in

  • What has been the recent revenue trend for Apium Pharmaceutical Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Apium Pharmaceutical Private Limited has risen by 5.46%.

  • What change has been observed in the net worth of Apium Pharmaceutical Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Apium Pharmaceutical Private Limited has experienced an upsurge of 51.95%.

  • When was the last Balance Sheet of Apium Pharmaceutical Private Limited filed with the ROC?

    The most recent Balance Sheet for Apium Pharmaceutical Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Drug Formulation & Development